We started by verifying that perturbed regulation by Kat2a had functional consequences for the translation machinery by performing polysomal profiling of MLL-AF9-carrying MOLM-13 AML cells in which KAT2A activity was inhibited by the MB-3 inhibitor (Tzelepis et al., 2016). This evidence concerns the gene KAT2A and acute myeloid leukemia.